A Phase II Trial of Endostar Combined With Gemcitabine and Cisplatin Chemotherapy in Patients With Metastatic Nasopharyngeal Carcinoma (NCT01612286)

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504014x13983417587401 ◽

2014 ◽

Vol 21 (6) ◽

pp. 317-323 ◽

Author(s):

Ting Jin ◽

Bin Li ◽

Xiao-Zhong Chen

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Nasopharyngeal Carcinoma ◽

Gemcitabine And Cisplatin

Download Full-text

Randomized Phase II Trial of Gemcitabine and Cisplatin (GP) versus Docetaxel and Cisplatin (TP) as Induction Chemotherapy followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.2288 ◽

2020 ◽

Vol 108 (3) ◽

pp. S106

Author(s):

J. Zang

Keyword(s):

Nasopharyngeal Carcinoma ◽

Induction Chemotherapy ◽

Phase Ii ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Trial ◽

Randomized Phase Ii ◽

Gemcitabine And Cisplatin

Download Full-text

Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: a multicenter prospective Phase II trial

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyv083 ◽

2015 ◽

Vol 45 (9) ◽

pp. 819-827 ◽

Author(s):

Jason Chia-Hsun Hsieh ◽

Cheng-Lung Hsu ◽

Shu-Hang Ng ◽

Cheng-Hsu Wang ◽

Kuan-Der Lee ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Nasopharyngeal Carcinoma ◽

Prospective Phase

Download Full-text

Bevacizumab versus placebo in combination with paclitaxel and carboplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase II trial

ESMO Open ◽

10.1016/j.esmoop.2021.100313 ◽

2021 ◽

Vol 6 (6) ◽

pp. 100313

Author(s):

T. Zhou ◽

Y. Yang ◽

S. Ma ◽

L. Lin ◽

T. Zhou ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

Metastatic Nasopharyngeal Carcinoma ◽

Open Label Phase ◽

First Line Treatment

Download Full-text

A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma

American Journal of Clinical Oncology ◽

10.1097/coc.0b013e31820dbdcc ◽

2012 ◽

Vol 35 (3) ◽

pp. 255-260 ◽

Author(s):

Benoit You ◽

Christophe Le Tourneau ◽

Eric X. Chen ◽

Lisa Wang ◽

Andrea Jarvi ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Maintenance Treatment ◽

Phase Ii Trial ◽

Platinum Based Chemotherapy ◽

Metastatic Nasopharyngeal Carcinoma

Download Full-text

First-line paclitaxel plus carboplatin with/without bevacizumab in recurrent or metastatic nasopharyngeal carcinoma: A multicenter, randomized, open-label, phase II trial

Annals of Oncology ◽

10.1093/annonc/mdx374.009 ◽

2017 ◽

Vol 28 ◽

pp. v376-v377

Author(s):

L. Zhang ◽

Y. Huang ◽

Y. Yang ◽

S. Ma ◽

X. Lin ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Nasopharyngeal Carcinoma ◽

Open Label Phase

Download Full-text

A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma

Oral Oncology ◽

10.1016/s1368-8375(01)00134-8 ◽

2002 ◽

Vol 38 (7) ◽

pp. 686-690 ◽

Author(s):

J McCarthy

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Nasopharyngeal Carcinoma

Download Full-text

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

Annals of Oncology ◽

10.1023/a:1008390929826 ◽

1999 ◽

Vol 10 (2) ◽

pp. 235-238 ◽

Author(s):

E.-H. Tan ◽

K.S. Khoo ◽

J. Wee ◽

K.W. Fong ◽

K.S. Lee ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Asian Patients ◽

Metastatic Nasopharyngeal Carcinoma

Download Full-text

A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a058703 ◽

1994 ◽

Vol 5 (1) ◽

pp. 87-89 ◽

Author(s):

E. Au ◽

P.-T. Ang

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Nasopharyngeal Carcinoma

Download Full-text

8527 A phase II trial of erlotinib after gemcitabine plus platinum-based chemotherapy in patients (pts) with recurrent and/or metastatic nasopharyngeal carcinoma (NPC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71618-0 ◽

2009 ◽

Vol 7 (2) ◽

pp. 478-479 ◽

Author(s):

B. You ◽

C. Le Tourneau ◽

E.X. Chen ◽

S.F. Chin ◽

L. Wang ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Platinum Based Chemotherapy ◽

Metastatic Nasopharyngeal Carcinoma

Download Full-text

Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma

Drug Design Development and Therapy ◽

10.2147/dddt.s95946 ◽

2015 ◽

pp. 6401 ◽

Author(s):

Pei-Jian Peng ◽

Bao-Jun Lv ◽

Con Tang ◽

Hai Liao ◽

Zhong Lin ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Nasopharyngeal Carcinoma

Download Full-text